Skip to main content
Clinical Trials/NCT05106530
NCT05106530UnknownNot Applicable

Arrhythmogenic Risk Assessment in Coronary Artery Ectasia Patients

Assiut University1 site in 1 country90 target enrollmentStarted: January 1, 2022Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Enrollment
90
Locations
1
Primary Endpoint
Precence of arrhythmias in 24 hours Holter monitoring

Study Overview

Brief Summary

The investigators thought to explore arrhythmias outcome - hidden arrhythmias, ECG features: Tp-Te interval and Tp-Te/QTc ratio, fQRS among patients with coronary artery ectasia as compared to normal coronary artery patients.

Detailed Description

All patients will be subjected to:

A. Full history taking:

  • Including age, sex, history of DM, HTN, dyslipidemia and Body surface area.

B. Holter monitoring for 24 hours:

  • Heart rate variability
  • Hidden arrhythmias
  • Hidden ischemia by monitoring ST segment changes

Study Design

Study Type
Observational
Observational Model
Case Control
Time Perspective
Other

Eligibility Criteria

Ages
18 Years to 70 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Subjects with suspected CAD who are referred for elective coronary angiography and/or interventions

Exclusion Criteria

  • Patients with a history of cardiomyopathy and myocardial infarction (MI), left ventricular hypertrophy (LVH), pathological Q wave on ECG, typical left bundle block or right bundle block, incomplete right bundle block, or paced rhythm on ECG.
  • Patients with severe renal impairment
  • Post CABG patients
  • Patients of acute coronary syndrome

Outcomes

Primary Outcomes

Precence of arrhythmias in 24 hours Holter monitoring

Time Frame: 1 year

Incidence of arrhythmias in Holter monitoring among coronary artery ectasia patients as compared to normal coronary artery patients.

Secondary Outcomes

  • • Heart rate variability in Holter monitoring(1 year)
  • • Silent ischemia as detected by Holter(1 years)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Mark Mohsen Nady Kamel

Resident at Cardiology Department

Assiut University

Study Sites (1)

Loading locations...

Similar Trials